You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radioligand

Showing 1 - 25 of 344
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • SPECT/CT
  • Grand Rapids, Michigan
    BAMF Health
Apr 19, 2023

Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)

Recruiting
  • Normal Physiology
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)

    Recruiting
    • Prostate Cancer
    • London, Ontario, Canada
      London Health Sciences Centre
    Nov 22, 2022

    Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

    Active, not recruiting
    • Prostate Cancer
    • +5 more
    • 131I-PSMA-1095 Radioligand Therapy (RLT)
    • Montreal, Quebec, Canada
      Stephan Probst
    Oct 24, 2022

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

    Recruiting
    • Salivary Gland Cancer
    • +2 more
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Oct 27, 2022

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 8, 2023

    Mechanisms of Resistance to PSMA Radioligand Therapy

    Recruiting
    • Prostate Cancer
    • Single-photon emission computed tomography
    • +2 more
    • Los Angeles, California
    • +2 more
    Jun 22, 2022

    Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

    Not yet recruiting
    • Carcinoid Tumor Lung
    • +2 more
    • 212-Lead Pentixather
    • 203-Lead Pentixather SPECT/CT
    • Iowa City, Iowa
      The University of Iowa Theranostics Center
    Sep 23, 2022

    177Lu-EB-FAPI Trial in Beijing (68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy)

    Recruiting
    • 177Lu-EB-FAPI
    • 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    May 27, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Image Guided Biopsy
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jun 17, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • Toronto, Ontario, Canada
      University Health Network - Princess Margaret Cancer Centre
    Aug 16, 2022

    Healthy Trial in New Haven (LY3857210)

    Recruiting
    • Healthy
    • New Haven, Connecticut
      Invicro, Institute for Neurodegenerative Disorders
    Sep 27, 2022

    Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

    Not yet recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Biospecimen Collection
    • +6 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Oct 25, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)

    Recruiting
    • Renal Cell Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Dec 24, 2021

    Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Oslo, Norway
      Oslo University Hospital
    Feb 13, 2023

    Healthy Controls Trial in Stanford ([18F]-FTC-146)

    Active, not recruiting
    • Healthy Controls
    • Stanford, California
      Department of Psychiatry and Behavioral Sciences
    Jun 15, 2022

    Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

    Not yet recruiting
    • Prostate Cancer
    • rhPSMA-7.3 (18F)
    • Bala-Cynwyd, Pennsylvania
      MidLantic Urology
    Mar 22, 2023

    Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)

    Not yet recruiting
    • Prostate Cancer
    • 177Lu-DOTA-TLX591
    • St Leonards, New South Wales, Australia
    • +1 more
    Jul 18, 2022

    MDD Trial in London (MIJ821)

    Not yet recruiting
    • Major Depressive Disorder
    • London, United Kingdom
      Parexel Early Phase Clinical Unit (LONDON)
    Dec 18, 2022

    Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

    Recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • 225^Ac-PSMA-617
    • 68^Ga-PSMA-11
    • Darlinghurst, Australia
    • +1 more
    Nov 23, 2022

    Anorexia Nervosa Trial in Saint-Étienne (PET imaging using [11C]DASB radioligand., Eye Tracker)

    Recruiting
    • Anorexia Nervosa
    • PET imaging using [11C]DASB radioligand.
    • Eye Tracker
    • Saint-Étienne, France
      CHU de Saint-Etienne
    Feb 7, 2022

    Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2

    Recruiting
    • Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
    • Duarte, California
    • +12 more
    Jul 6, 2022

    Depression Trial run by the NIMH ([C-11]T-1650, BPN14770)

    Completed
    Has Results
    • Depression
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 25, 2021

    Prostate Cancer Trial in Amsterdam, Groningen, Nijmegen (177Lu-PSMA-617)

    Recruiting
    • Prostate Cancer
    • Amsterdam, Netherlands
    • +3 more
    Oct 17, 2021